Barr second-quarter earnings show impressive jump from year-ago

Barr Pharmaceuticals posted impressive second-quarter earnings, with generic sales increasing to $487 million, compared with...

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Login or Register to post a comment.